These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35750263)

  • 1. Characteristics of statewide prescription drug monitoring programs and potentially inappropriate opioid prescribing to patients with non-cancer chronic pain: A machine learning application.
    Lin HC; Wang Z; Hu YH; Simon K; Buu A
    Prev Med; 2022 Aug; 161():107116. PubMed ID: 35750263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
    Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
    Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mandatory use of prescription drug monitoring program and benzodiazepine prescribing among U.S. Medicaid enrollees.
    Liang D; Guo H; Shi Y
    Subst Abus; 2021; 42(3):294-301. PubMed ID: 31697195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.
    Strickler GK; Zhang K; Halpin JF; Bohnert ASB; Baldwin GT; Kreiner PW
    Drug Alcohol Depend; 2019 Jun; 199():1-9. PubMed ID: 30954863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California's prescription drug monitoring program.
    Castillo-Carniglia A; González-Santa Cruz A; Cerdá M; Delcher C; Shev AB; Wintemute GJ; Henry SG
    Drug Alcohol Depend; 2021 Jan; 218():108405. PubMed ID: 33234299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in opioid and other analgesic prescribing following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis of early outcomes.
    Nielsen S; Picco L; Russell G; Pearce C; Andrew NE; Lubman DI; Bell JS; Buchbinder R; Xia T
    Int J Drug Policy; 2023 Jul; 117():104053. PubMed ID: 37209441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020.
    Adalbert JR; Syal A; Varshney K; George B; Hom J; Ilyas AM
    BMC Health Serv Res; 2023 Apr; 23(1):364. PubMed ID: 37046254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
    Manders L; Abd-Elsayed A
    Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstate data sharing of prescription drug monitoring programs and associated opioid prescriptions among patients with non-cancer chronic pain.
    Lin HC; Wang Z; Simoni-Wastila L; Boyd C; Buu A
    Prev Med; 2019 Jan; 118():59-65. PubMed ID: 30316875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic.
    Stein BD; Sheng F; Taylor EA; Dick AW; Sorbero M; Pacula RL
    Drug Alcohol Depend; 2022 Feb; 231():109232. PubMed ID: 35007956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of state rules on opioid prescribing in Indiana.
    Al Achkar M; Grannis S; Revere D; MacKie P; Howard M; Gupta S
    BMC Health Serv Res; 2018 Jan; 18(1):29. PubMed ID: 29347984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers.
    Deyo RA; Hallvik SE; Hildebran C; Marino M; Springer R; Irvine JM; O'Kane N; Van Otterloo J; Wright DA; Leichtling G; Millet LM; Carson J; Wakeland W; McCarty D
    J Pain; 2018 Feb; 19(2):166-177. PubMed ID: 29054493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of automatic physician review of prescription drug monitoring program data on opioid prescribing in a Maryland statewide hospital system.
    Stryckman B; Schoenbaum A; Klein J; Chasm R; Onukwugha E; Dezman ZD
    J Opioid Manag; 2022; 18(6):547-556. PubMed ID: 36523206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
    Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
    Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol: mixed-methods study to evaluate implementation, enforcement, and outcomes of U.S. state laws intended to curb high-risk opioid prescribing.
    McGinty EE; Stuart EA; Caleb Alexander G; Barry CL; Bicket MC; Rutkow L
    Implement Sci; 2018 Feb; 13(1):37. PubMed ID: 29482599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Iowa's Prescription Monitoring Program on Opioid Pain Reliever Prescribing Patterns: An Interrupted Time Series Study 2003-2014.
    Ranapurwala SI; Carnahan RM; Brown G; Hinman J; Casteel C
    Pain Med; 2019 Feb; 20(2):290-300. PubMed ID: 29509935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program.
    Shenoy R; Wagner Z; Kirkegaard A; Romanelli RJ; Mudiganti S; Mariano L; Martinez M; Zanocco K; Watkins KE
    JAMA Health Forum; 2021 Oct; 2(10):e212924. PubMed ID: 35977161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a legislative mandate on opioid prescribing for back pain in the emergency department.
    Khobrani M; Perona S; Patanwala AE
    Am J Emerg Med; 2019 Nov; 37(11):2035-2038. PubMed ID: 30824275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of targeted insurer-mandated prescription monitoring on opioid prescribing patterns.
    Fleming JN; Zhang J; Taber DJ; McCauley JL; Schumann S; Mauldin PD; Ball S
    J Am Pharm Assoc (2003); 2020; 60(4):559-564. PubMed ID: 32033899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.